Log in to save to my catalogue

Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree...

Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3230467638

Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer

About this item

Full title

Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer

Publisher

Athens: International Institute of Anticancer Research

Journal title

Cancer genomics & proteomics, 2024-05, Vol.21 (3), p.316

Language

English

Formats

Publication information

Publisher

Athens: International Institute of Anticancer Research

More information

Scope and Contents

Contents

Background/Aim: Patients with triple-negative breast cancer (TNBC) have a high rate of recurrence within 3 years of diagnosis and a high rate of death within 5 years compared to other subtypes. The number of clinical trials investigating various new agents and combination therapies has recently increased; however, current strategies benefit only a...

Alternative Titles

Full title

Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative Breast Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3230467638

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3230467638

Other Identifiers

ISSN

1109-6535

E-ISSN

1790-6245

DOI

10.21873/cgp.20450

How to access this item